Literature DB >> 34919268

Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19.

Tugce Apaydin1, Hamza Polat2, Ceyda Dincer Yazan1, Can Ilgin3, Onur Elbasan1, Saida Dashdamirova1, Feyza Bayram2, Elif Tukenmez Tigen4, Ozan Unlu5, Ahmet F Tekin5, Ebru Arslan2, Ipek Yilmaz2, Goncagul Haklar5, Pınar Ata2, Hulya Gozu1.   

Abstract

PURPOSE: Vitamin D deficiency has emerged as another potential risk factor for coronavirus disease (COVID-19) due to the immunomodulatory effects of 25 hydroxyvitamin D [25 (OH)D]. Vitamin D receptor (VDR) gene polymorphisms such as Fok I, Bsm I, Apa I, and Taq I are also associated with different courses of viral infections. This study aimed to evaluate the association between the VDR gene polymorphism at Fok I, Taq I, Bsm I, and Apa I genotypes and the prognosis of COVID-19 in respect to vitamin D deficiency.
METHODS: Two-hundred ninety-seven patients with COVID-19 were enrolled. Serum 25 (OH)D levels were measured. Four variant regions of the VDR gene, FokI, BsmI, ApaI, and TaqI were determined.
RESULTS: Eighty-three percent of subjects had vitamin D deficiency, and 40.7% of the whole group had severe deficiency. Median 25 (OH)D level was 11.97 ng/ml. Vitamin D levels were not related to inflammatory markers, disease severity, admission to intensive care unit (ICU), and mortality. While disease severity was related to Fok I Ff genotype, it was Taq TT genotype for ICU admission. Moreover, the ApaI aa genotype was common among the patients who were died. None of the deceased subjects had the Fok I FF genotype.
CONCLUSION: 25 (OH)D levels were not related to the severity and mortality of COVID-19. VDR gene polymorphisms are independently associated with the severity of COVID-19 and the survival of patients.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Apa I; COVID-19; Fok I; VDR polymorphism; vitamin D deficiency

Mesh:

Substances:

Year:  2021        PMID: 34919268     DOI: 10.1111/cen.14664

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.523


  7 in total

1.  Reply - Letter to the editor: "Micronutrient supplementation, COVID-19 vaccination and adverse effect".

Authors:  Rinkoo Dalan; Bernhard O Boehm
Journal:  Clin Nutr ESPEN       Date:  2022-03-04

Review 2.  The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity: A systematic review and meta-analysis.

Authors:  Zorana Dobrijevic; Dragana Robajac; Nikola Gligorijevic; Miloš Šunderic; Ana Penezic; Goran Miljuš; Olgica Nedic
Journal:  EXCLI J       Date:  2022-06-20       Impact factor: 4.022

3.  Vitamin D Receptor Genetic Polymorphisms Associate With a Decreased Susceptibility to Extremity Osteomyelitis Partly by Inhibiting Macrophage Apoptosis Through Inhibition of Excessive ROS Production via VDR-Bmi1 Signaling.

Authors:  Xing-Qi Zhao; Hao-Yang Wan; Si-Ying He; Han-Jun Qin; Bin Yu; Nan Jiang
Journal:  Front Physiol       Date:  2022-07-25       Impact factor: 4.755

Review 4.  Vitamin D and COVID-19-Revisited.

Authors:  Sreedhar Subramanian; George Griffin; Martin Hewison; Julian Hopkin; Rose Anne Kenny; Eamon Laird; Richard Quinton; David Thickett; Jonathan M Rhodes
Journal:  J Intern Med       Date:  2022-07-15       Impact factor: 13.068

5.  Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19.

Authors:  Nancy M S Zeidan; Hanan M Abd El Lateef; Dalia M Selim; Suzan A Razek; Ghada A B Abd-Elrehim; Mohamed Nashat; Noha ElGyar; Nevin M Waked; Attia A Soliman; Ahmed A Elhewala; Mohamed M M Shehab; Ahmed A A Ibraheem; Hassan Shehata; Yousif M Yousif; Nagwa E Akeel; Mustafa I A Hashem; Amani A Ahmed; Ahmed A Emam; Mohamed M Abdelmohsen; Mohamed F Ahmed; Ahmed S E Saleh; Heba H Eltrawy; Gehan H Shahin; Rehab M Nabil; Thoraya A Hosny; Mohamed R Abdelhamed; Mona R Afify; Mohanned T Alharbi; Mohammed K Nagshabandi; Muyassar K Tarabulsi; Sherif F Osman; Amal S M Abd-Elrazek; Manal M Rashad; Sonya A A El-Gaaly; Said A B Gad; Mohamed Y Mohamed; Khalil Abdelkhalek; Aly A Yousef
Journal:  Pediatr Res       Date:  2022-09-09       Impact factor: 3.953

6.  Commentary: Vitamin D status in relation to the clinical outcome of hospitalized COVID-19 patients.

Authors:  Wael Hafez
Journal:  Front Med (Lausanne)       Date:  2022-08-12

Review 7.  Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity.

Authors:  Kajal Gupta; Gaganpreet Kaur; Tejal Pathak; Indranil Banerjee
Journal:  Gene       Date:  2022-08-17       Impact factor: 3.913

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.